ZoomMed inc.

ZoomMed inc.

February 08, 2006 23:59 ET

ZoomMed announces the second closing of an offering

MONTREAL, Feb. 8 - ZoomMed inc. ("ZoomMed") (TSX Venture
Exchange: ZMD) announces that, on February 8, 2006, pursuant to an amended
prospectus dated December 20, 2005, it completed a second closing resulting in
the issuance of 3,622,000 common shares of the share capital of ZoomMed, at a
price of $0.20 per share. The gross proceeds resulting from the issuance of
these shares are $724,400.

In connection with this offering of shares, ZoomMed has paid to Versant
Partners Inc. ("Versant"), the agent, a cash commission, and has issued to
Versant, as remuneration, warrants entitling it to purchase 181,100 common
shares of ZoomMed, at a price of $0.20 per share, for a period of 18 months.

Pursuant to the amended prospectus dated December 20, 2005, the
corporation issued, to date, a total of 5,351,500 common shares of its share
capital for total gross proceeds of $1,070,300.

ZoomMed is presently developing a new electronic tool "ZRx Prescriber",
intended to change the way drugs are prescribed and dispensed throughout
Canada. This handheld prescribing system device, equipped with tools such as a
therapeutic advisor as well as a medication interaction manager, will enable
doctors to fill prescriptions and to electronically transmit them in a fast
and secure mode. This user friendly Web product, designed for doctors, will
use the latest "Pocket PC" technologies.

The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.

Contact Information

  • Yves Marmet
    President and Chief Executive
    (450) 678-5457